Stewart White

Angel Biotechnology Holdings Plc operated as a contract bio-manufacturing company that offers process development, pre-GMP and cGMP manufacturing services. The company specialized in offering the cGMP manufacture of advanced biologics including stem cells, cell therapies, recombinant proteins, antibodies and viruses for clinical trial use and commercial sale. It also provided development and manufacturing support for production of biologics working from laboratory scale to development of a robust manufacturing process. Angel Biotechnology was founded on December 7, 2000 and was headquartered in Edinburgh, the United Kingdom.

Part of Rosen's Diversified, Inc., Angel Biomedical Ltd. is a British company that manufactures biomaterial and medical grade collagen components. The company is based in Cramlington, UK. Angel Biomedical was acquired by Collagen Solutions (UK) Ltd., a SUB of Rosen's Diversified, Inc. from Angel Biotechnology Holdings Plc on March 18, 2013.

Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom.

The Electrospinning Co. Ltd. develops and manufactures electro spun polymer scaffolds. The firm offers Minetix 3D tissue culture plates. It sell a range of ready-to-use, sterile tissue culture plates containing the Mimetix scaffold for tissue engineering, regenerative medicine and drug discovery research. The company was founded by Robert Stevens and David Mansel Williams in 2010 and is headquartered in Didcot, the United Kingdom.

Collagen Solutions (US) LLC is a holding company, which engages in the supply, development, and manufacture of medical grade collagen components and biomaterials. The company offers products for the use in regenerative medicine, medical devices, and in-vitro diagnostics and research. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; and Asia. The company was founded on March 15, 2013 and is headquartered in Glasgow, the United Kingdom.

Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom.

Taragenyx Ltd. operates as an entrepreneurial medical technologies company. It discovers, develops and intends to commercialize human implant treatments targeting important therapeutic needs. The company was founded by Raman Bedi in August 06, 2010 and is headquartered in Glasgow, the United Kingdom.